• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五聚体蛋白3与冠状动脉疾病严重程度之间的关联。

Associations between pentraxin 3 and severity of coronary artery disease.

作者信息

Liu Hua, Guan Shaofeng, Fang Weiyi, Yuan Fang, Zhang Min, Qu Xinkai

机构信息

Department of Cardiology, Shanghai Chest Hospital, Affiliated to Shanghai Jiao Tong University, Shanghai, China.

出版信息

BMJ Open. 2015 Apr 8;5(4):e007123. doi: 10.1136/bmjopen-2014-007123.

DOI:10.1136/bmjopen-2014-007123
PMID:25854969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4390731/
Abstract

OBJECTIVE

To investigate the associations between plasma levels of pentraxins 3 (PTX3) and C reactive protein (CRP) and the severity of coronary artery lesions.

DESIGN AND METHODS

60 patients with coronary heart disease (CHD) who underwent coronary angiography (CAG) in our hospital were included. Plasma was collected during CAG. The coronary Gensini score was used to evaluate the severity of coronary artery lesions. Associations between Gensini scores and plasma levels of PTX3 and CRP were analysed. Patients with estimated glomerular filtration rate <60 mL/min/1.73 m(2) were included in the chronic renal dysfunction subgroup.

RESULTS

A linear correlation was observed between PTX3 and the Gensini score (r=0.513, p<0.001). One-way analysis of variance showed that PTX3 levels were significantly higher in patients with Gensini scores >90 compared with patients with scores of 46-90 or <45 (0-45:4.8±0.8, 46-90:6.7±1.2, >90:7.7±2.0, p<0.001). Stepwise multiple linear regression showed that PTX3 levels were significantly associated with Gensini score in patients with chronic renal dysfunction (p=0.012), while no significant association was found for CRP.

CONCLUSIONS

PTX3 levers were positively associated with the severity of coronary artery lesions. PTX3 is closely associated with the severity of coronary artery stenosis in patients with chronic renal dysfunction.

摘要

目的

探讨血浆中五聚体3(PTX3)和C反应蛋白(CRP)水平与冠状动脉病变严重程度之间的关联。

设计与方法

纳入我院60例行冠状动脉造影(CAG)的冠心病(CHD)患者。在CAG过程中采集血浆。采用冠状动脉Gensini评分评估冠状动脉病变的严重程度。分析Gensini评分与PTX3和CRP血浆水平之间的关联。估算肾小球滤过率<60 mL/min/1.73 m(2)的患者被纳入慢性肾功能不全亚组。

结果

观察到PTX3与Gensini评分之间存在线性相关性(r = 0.513,p<0.001)。单因素方差分析显示,与Gensini评分为46 - 90或<45的患者相比,Gensini评分>90的患者PTX3水平显著更高(0 - 45:4.8±0.8,46 - 90:6.7±1.2,>90:7.7±2.0,p<0.001)。逐步多元线性回归显示,在慢性肾功能不全患者中,PTX3水平与Gensini评分显著相关(p = 0.012),而CRP未发现显著关联。

结论

PTX3水平与冠状动脉病变严重程度呈正相关。PTX3与慢性肾功能不全患者冠状动脉狭窄的严重程度密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f4/4390731/0f3505d68d3e/bmjopen2014007123f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f4/4390731/0be71cdfdc40/bmjopen2014007123f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f4/4390731/0f3505d68d3e/bmjopen2014007123f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f4/4390731/0be71cdfdc40/bmjopen2014007123f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f4/4390731/0f3505d68d3e/bmjopen2014007123f02.jpg

相似文献

1
Associations between pentraxin 3 and severity of coronary artery disease.五聚体蛋白3与冠状动脉疾病严重程度之间的关联。
BMJ Open. 2015 Apr 8;5(4):e007123. doi: 10.1136/bmjopen-2014-007123.
2
The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker.炎症生物标志物在冠心病中的临床价值:PTX3 作为一种新的炎症标志物。
Exp Gerontol. 2017 Oct 15;97:64-67. doi: 10.1016/j.exger.2017.07.018. Epub 2017 Aug 1.
3
Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease.循环 pentraxin 在冠状动脉疾病中危患者中的诊断价值逐渐增加。
Heart. 2013 May;99(9):640-8. doi: 10.1136/heartjnl-2012-303560. Epub 2013 Mar 6.
4
Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.血清五聚素 3 水平与稳定性心绞痛患者冠状动脉疾病的复杂性和严重程度相关。
J Investig Med. 2013 Feb;61(2):278-85. doi: 10.2310/JIM.0b013e31827c2971.
5
Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.脂蛋白(a)在预测2型糖尿病患者新发冠状动脉疾病严重程度中的作用:一项Gensini评分评估。
Diab Vasc Dis Res. 2015 Jul;12(4):258-64. doi: 10.1177/1479164115579004. Epub 2015 Apr 10.
6
Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.五聚素 3 浓度升高与冠状动脉斑块易损性相关。
J Cardiol. 2011 Sep;58(2):151-7. doi: 10.1016/j.jjcc.2011.04.005. Epub 2011 Jun 14.
7
Association of Serum Prealbumin with Angiographic Severity in Patients with Acute Coronary Syndrome.血清前白蛋白与急性冠状动脉综合征患者血管造影严重程度的关系。
Med Sci Monit. 2017 Aug 21;23:4041-4049. doi: 10.12659/msm.902348.
8
The potential value of Copeptin and Pentraxin3 for evaluating the severity of coronary stenosis in patients with coronary artery disease.Copeptin 和 Pentraxin3 评估冠心病患者冠状动脉狭窄严重程度的潜在价值。
Clin Biochem. 2021 Jan;87:32-38. doi: 10.1016/j.clinbiochem.2020.10.008. Epub 2020 Oct 17.
9
Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.稳定型冠状动脉疾病中3型 pentraxin 的浓度取决于临床表现。
Eur Cytokine Netw. 2014 Jul-Sep;25(3):41-5. doi: 10.1684/ecn.2014.0354.
10
Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.尿酸和五聚素-3 水平与 2 期和 3 期肾病患者的冠心病风险独立相关。
Am J Nephrol. 2011;33(4):325-31. doi: 10.1159/000324916. Epub 2011 Mar 10.

引用本文的文献

1
The m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy.SOX18的m6A修饰导致脓毒症诱导的心肌病中PTX3增加和心肌细胞焦亡。
Theranostics. 2025 Feb 24;15(8):3532-3550. doi: 10.7150/thno.103809. eCollection 2025.
2
Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease.他汀类药物对冠状动脉疾病患者炎症标志物的影响。
J Lab Physicians. 2023 Apr 18;15(4):498-502. doi: 10.1055/s-0043-1768167. eCollection 2023 Dec.
3
Association of Serum Pentraxin 3 and High-Sensitivity C-Reactive Protein with Severity of Coronary Stenosis.

本文引用的文献

1
Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.炎症生物标志物五聚素 3(PTX3)与肥胖、体脂储存和体重减轻的关系。
Obesity (Silver Spring). 2014 May;22(5):1373-9. doi: 10.1002/oby.20695. Epub 2014 Jan 25.
2
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?高敏 C 反应蛋白与心血管疾病:确凿的信念还是难以捉摸的关联?
J Am Coll Cardiol. 2013 Jul 30;62(5):397-408. doi: 10.1016/j.jacc.2013.05.016. Epub 2013 May 30.
3
Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
血清五聚体蛋白3及高敏C反应蛋白与冠状动脉狭窄严重程度的关联
Int J Appl Basic Med Res. 2022 Oct-Dec;12(4):249-253. doi: 10.4103/ijabmr.ijabmr_203_22. Epub 2022 Dec 19.
4
Inflammatory cell infiltrates, hypoxia, vascularization, pentraxin 3 and osteoprotegerin in abdominal aortic aneurysms - A quantitative histological study.腹主动脉瘤中的炎症细胞浸润、缺氧、血管生成、五聚素 3 和骨保护素 - 一项定量组织学研究。
PLoS One. 2019 Nov 8;14(11):e0224818. doi: 10.1371/journal.pone.0224818. eCollection 2019.
5
Association of coronary dominance with the severity of coronary artery disease: a cross-sectional study in Shaanxi Province, China.优势型冠状动脉与冠状动脉疾病严重程度的相关性:中国陕西省的一项横断面研究。
BMJ Open. 2018 Nov 8;8(11):e021292. doi: 10.1136/bmjopen-2017-021292.
6
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.有机尿毒症潴留溶质的生化和临床影响:全面更新。
Toxins (Basel). 2018 Jan 8;10(1):33. doi: 10.3390/toxins10010033.
血清五聚素 3 水平与稳定性心绞痛患者冠状动脉疾病的复杂性和严重程度相关。
J Investig Med. 2013 Feb;61(2):278-85. doi: 10.2310/JIM.0b013e31827c2971.
4
[Inflammatory process in atherogenesis: new facts about old flame].[动脉粥样硬化中的炎症过程:旧有问题的新进展]
Med Pregl. 2012 Sep-Oct;65(9-10):388-95. doi: 10.2298/mpns1210388v.
5
Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury.内皮素 pentraxin 3 有助于小鼠缺血性急性肾损伤。
Kidney Int. 2012 Dec;82(11):1195-207. doi: 10.1038/ki.2012.268. Epub 2012 Aug 15.
6
[New biomarkers for cardiovascular risk evaluation].[用于心血管风险评估的新型生物标志物]
Rev Prat. 2012 Jun;62(6):783-5.
7
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.Pentraxin-3 在慢性心力衰竭中的作用:CORONA 和 GISSI-HF 试验。
Eur J Heart Fail. 2012 Sep;14(9):992-9. doi: 10.1093/eurjhf/hfs092. Epub 2012 Jun 27.
8
Acute phase proteins in acute coronary syndrome: an up-to-date.急性冠状动脉综合征中的急性期蛋白:最新进展
Cardiovasc Hematol Agents Med Chem. 2012 Dec;10(4):352-61. doi: 10.2174/187152512803530298.
9
Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials.无端制造争议:C反应蛋白在CARE、AFCAPS/TexCAPS、PROVE IT、REVERSAL、A to Z、JUPITER、心脏保护研究及ASCOT试验中的重要作用
Eur Heart J. 2012 Feb;33(4):430-2. doi: 10.1093/eurheartj/ehr310. Epub 2011 Sep 6.
10
Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.五聚素 3 浓度升高与冠状动脉斑块易损性相关。
J Cardiol. 2011 Sep;58(2):151-7. doi: 10.1016/j.jjcc.2011.04.005. Epub 2011 Jun 14.